Immunodiagnostic Systems Holdings PLC (IDH) Insider Paul James Martin Acquires 2,000 Shares of Stock
Immunodiagnostic Systems Holdings PLC (LON:IDH) insider Paul James Martin bought 2,000 shares of the firm’s stock in a transaction dated Wednesday, March 21st. The shares were acquired at an average cost of GBX 228 ($3.15) per share, with a total value of £4,560 ($6,300.08).
Shares of Immunodiagnostic Systems stock opened at GBX 230 ($3.18) on Thursday. Immunodiagnostic Systems Holdings PLC has a 12-month low of GBX 210 ($2.90) and a 12-month high of GBX 345 ($4.77). The stock has a market capitalization of $73.74 and a price-to-earnings ratio of 2,300.00.
About Immunodiagnostic Systems
Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology.
Receive News & Ratings for Immunodiagnostic Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunodiagnostic Systems and related companies with MarketBeat.com's FREE daily email newsletter.